Celldex Therapeutics
CLDX
CLDX
186 hedge funds and large institutions have $2.18B invested in Celldex Therapeutics in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
35% less call options, than puts
Call options by funds: $35.7M | Put options by funds: $55.1M
Holders
186
Holding in Top 10
2
Calls
$35.7M
Puts
$55.1M
Top Buyers
| 1 | +$46.4M | |
| 2 | +$20.5M | |
| 3 | +$19M | |
| 4 |
RI
RTW Investments
New York
|
+$11.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.9M |
Top Sellers
| 1 | -$38.3M | |
| 2 | -$17M | |
| 3 | -$16.7M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$14.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$13M |